Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
5.69M
-
Shares change
-
-356K
-
Total reported value, excl. options
-
$88.1M
-
Value change
-
+$32.6M
-
Number of buys
-
21
-
Number of sells
-
-13
-
Price
-
$9.15
Significant Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q1 2021
42 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q1 2021.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.69M shares
of 51.9M outstanding shares and own 10.96% of the company stock.
Largest 10 shareholders include Stonepine Capital Management, LLC (1.02M shares), Corriente Advisors, LLC (870K shares), VANGUARD GROUP INC (846K shares), Manatuck Hill Partners, LLC (571K shares), Point72 Asset Management, L.P. (552K shares), Ikarian Capital, LLC (415K shares), JACOB ASSET MANAGEMENT OF NEW YORK LLC (185K shares), Granite Point Capital Management, L.P. (184K shares), RENAISSANCE TECHNOLOGIES LLC (153K shares), and GEODE CAPITAL MANAGEMENT, LLC (128K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.